Download PDF
Horm Metab Res 1980; 12(11): 621-624
DOI: 10.1055/s-2007-999214
© Georg Thieme Verlag, Stuttgart · New York

Mode of Action of Somatostatin in Inhibiting Parathyroid Hormone Secretion

S. C. Kukreja, G. K. Hargis, E. N. Bowser, G. A. Williams
  • Section of Endocrinology, Departments of Medicine and Nuclear Medicine, VA West Side Medical Center and University of Illinois College of Medicine, Chicago, Illinois, U.S.A.
Further Information

Publication History

1980

1980

Publication Date:
22 April 2008 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

Effects of somatostatin on basal and low calcium-, isoproterenol- or dibutryl cyclic AMP (DBcAMP)-stimulated parathyroid hormone (PTH) secretion were evaluated in vitro with bovine parathyroid tissue. Low calcium, isoproterenol or DBcAMP alone significantly stimulated PTH secretion. Somatostatin 1 or 4 μg/ml significantly inhibited these stimulated PTH secretions. Inhibition of isoproterenol-stimulated PTH secretion was more complete than was the inhibition of low calcium- or DBcAMP-stimulated secretion. The studies indicate that somatostatin inhibits PTH secretion by an action distal to cAMP generation. The more complete inhibition of isoproterenol-stimulated PTH secretion suggests that somatostatin may also have additional effects on or proximal to the formation of cyclic AMP.

Key-Words

Somatostatin - PTH Secretion - Cyclic AMP - β-Adrenergic - Low Calcium

      >